These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 25879528)

  • 1. Keap1 expression has independent prognostic value in pancreatic adenocarcinomas.
    Isohookana J; Haapasaari KM; Soini Y; Karihtala P
    Diagn Pathol; 2015 Apr; 10():28. PubMed ID: 25879528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic and predictive values of Nrf2, Keap1, p16 and E-cadherin expression in ovarian epithelial carcinoma.
    Liew PL; Hsu CS; Liu WM; Lee YC; Lee YC; Chen CL
    Int J Clin Exp Pathol; 2015; 8(5):5642-9. PubMed ID: 26191276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nrf2/Keap1 Pathway and Expression of Oxidative Stress Lesions 8-hydroxy-2'-deoxyguanosine and Nitrotyrosine in Melanoma.
    Hintsala HR; Jokinen E; Haapasaari KM; Moza M; Ristimäki A; Soini Y; Koivunen J; Karihtala P
    Anticancer Res; 2016 Apr; 36(4):1497-506. PubMed ID: 27069125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical study of the Nrf2 pathway in colorectal cancer: Nrf2 expression is closely correlated to Keap1 in the tumor and Bach1 in the normal tissue.
    Chang LC; Fan CW; Tseng WK; Chen JR; Chein HP; Hwang CC; Hua CC
    Appl Immunohistochem Mol Morphol; 2013 Dec; 21(6):511-7. PubMed ID: 23455180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression and clinical significance of HSPA2 in pancreatic ductal adenocarcinoma.
    Zhang H; Gao H; Liu C; Kong Y; Wang C; Zhang H
    Diagn Pathol; 2015 Mar; 10():13. PubMed ID: 25890028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxidative stress and counteracting mechanisms in hormone receptor positive, triple-negative and basal-like breast carcinomas.
    Karihtala P; Kauppila S; Soini Y; Arja-Jukkola-Vuorinen
    BMC Cancer; 2011 Jun; 11():262. PubMed ID: 21693047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytoplasmic Keap1 Expression Is Associated With Poor Prognosis in Endometrial Cancer.
    Ahtikoski AM; Kangas J; Salonen R; Puistola U; Karihtala P
    Anticancer Res; 2019 Feb; 39(2):585-590. PubMed ID: 30711933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An immunohistochemical study of NFE2L2, KEAP1 and 8-hydroxy-2'-deoxyguanosine and the EMT markers SNAI2, ZEB1 and TWIST1 in metastatic melanoma.
    Hintsala HR; Haapasaari KM; Soini Y; Karihtala P
    Histol Histopathol; 2017 Feb; 32(2):129-136. PubMed ID: 27170270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High expression of delta-like ligand 4 predicts poor prognosis after curative resection for pancreatic cancer.
    Chen HT; Cai QC; Zheng JM; Man XH; Jiang H; Song B; Jin G; Zhu W; Li ZS
    Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S464-74. PubMed ID: 21822553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nuclear Nrf2 expression is related to a poor survival in pancreatic adenocarcinoma.
    Soini Y; Eskelinen M; Juvonen P; Kärjä V; Haapasaari KM; Saarela A; Karihtala P
    Pathol Res Pract; 2014 Jan; 210(1):35-9. PubMed ID: 24189098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased BTB-Kelch type substrate adaptor protein immunoreactivity associates with advanced stage and poor differentiation in renal cell carcinoma.
    Ronkainen H; Vaarala MH; Kauppila S; Soini Y; Paavonen TK; Rask J; Hirvikoski P
    Oncol Rep; 2009 Jun; 21(6):1519-23. PubMed ID: 19424632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. KEAP1 Genetic Polymorphisms Associate with Breast Cancer Risk and Survival Outcomes.
    Hartikainen JM; Tengström M; Winqvist R; Jukkola-Vuorinen A; Pylkäs K; Kosma VM; Soini Y; Mannermaa A
    Clin Cancer Res; 2015 Apr; 21(7):1591-601. PubMed ID: 25589623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between expression of IGFBP7 and clinicopathological variables in gastric cancer.
    Sato Y; Inokuchi M; Takagi Y; Otsuki S; Fujimori Y; Yanaka Y; Kobayashi K; Higuchi K; Kojima K; Kawano T
    J Clin Pathol; 2015 Oct; 68(10):795-801. PubMed ID: 26043748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression Patterns of Nrf2 and Keap1 in Ovarian Cancer Cells and their Prognostic Role in Disease Recurrence and Patient Survival.
    Cho HY; Kim K; Kim YB; Kim H; No JH
    Int J Gynecol Cancer; 2017 Mar; 27(3):412-419. PubMed ID: 28129239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 8-hydroxydeguanosine and nitrotyrosine are prognostic factors in urinary bladder carcinoma.
    Soini Y; Haapasaari KM; Vaarala MH; Turpeenniemi-Hujanen T; Kärjä V; Karihtala P
    Int J Clin Exp Pathol; 2011 Mar; 4(3):267-75. PubMed ID: 21487522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Keap1-Nrf2 signalling in pancreatic cancer.
    Hayes AJ; Skouras C; Haugk B; Charnley RM
    Int J Biochem Cell Biol; 2015 Aug; 65():288-99. PubMed ID: 26117456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Smad4 loss in esophageal adenocarcinoma is associated with an increased propensity for disease recurrence and poor survival.
    Singhi AD; Foxwell TJ; Nason K; Cressman KL; McGrath KM; Sun W; Bahary N; Zeh HJ; Levy RM; Luketich JD; Davison JM
    Am J Surg Pathol; 2015 Apr; 39(4):487-95. PubMed ID: 25634752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased expression of microRNA-124 is an independent unfavorable prognostic factor for patients with breast cancer.
    Dong LL; Chen LM; Wang WM; Zhang LM
    Diagn Pathol; 2015 Apr; 10():45. PubMed ID: 25924779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low RASSF6 expression in pancreatic ductal adenocarcinoma is associated with poor survival.
    Ye HL; Li DD; Lin Q; Zhou Y; Zhou QB; Zeng B; Fu ZQ; Gao WC; Liu YM; Chen RW; Li ZH; Chen RF
    World J Gastroenterol; 2015 Jun; 21(21):6621-30. PubMed ID: 26074700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mucin expression in endoscopic ultrasound-guided fine-needle aspiration specimens is a useful prognostic factor in pancreatic ductal adenocarcinoma.
    Higashi M; Yokoyama S; Yamamoto T; Goto Y; Kitazono I; Hiraki T; Taguchi H; Hashimoto S; Fukukura Y; Koriyama C; Mataki Y; Maemura K; Shinchi H; Jain M; Batra SK; Yonezawa S
    Pancreas; 2015 Jul; 44(5):728-34. PubMed ID: 25906442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.